CAVALIERI, STEFANO
CAVALIERI, STEFANO
Dipartimento di Oncologia ed Emato-Oncologia
A Prospectively Validated Prognostic Model for Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck Based on Radiomics of Computed Tomography Images
2021 S.A. Keek, F.W.R. Wesseling, H.C. Woodruff, J.E. van Timmeren, I.H. Nauta, T.K. Hoffmann, S. Cavalieri, G. Calareso, S. Primakov, R.T.H. Leijenaar, L. Licitra, M. Ravanelli, K. Scheckenbach, T. Poli, D. Lanfranco, M.R. Vergeer, C.R. Leemans, R.H. Brakenhoff, F.J.P. Hoebers, P. Lambin
A randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy of Aqualief™ mucoadhesive tablets in head and neck cancer patients who developed radiation-induced xerostomia
2021 N.A. Iacovelli, R. Ingargiola, N. Facchinetti, M. Franceschini, D.A. Romanello, P. Bossi, C. Bergamini, S. Alfieri, S. Cavalieri, G. Baron, G. Aldini, L. Locati, E. Orlandi
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial
2021 L.D. Locati, S. Cavalieri, C. Bergamini, C. Resteghini, E. Colombo, G. Calareso, L. Mariani, P. Quattrone, S. Alfieri, P. Bossi, F. Platini, I. Capone, L. Licitra
Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment
2019 D. Galbiati, S. Cavalieri, S. Alfieri, C. Resteghini, C. Bergamini, E. Orlandi, F. Platini, L. Locati, L. Giacomelli, L. Licitra, P. Bossi
Adjuvant androgen deprivation therapy for poor-risk, androgen receptor–positive salivary duct carcinoma
2019 W. van Boxtel, L.D. Locati, A.C.H. van Engen-van Grunsven, C. Bergamini, M.A. Jonker, E. Fiets, S. Cavalieri, S. Tooten, E. Bos, P. Quattrone, C.M.L. van Herpen, G.W. Verhaegh, J.A. Schalken, L. Licitra, C.M.L. van Herpen
AKR1C3 is a biomarker and druggable target for oropharyngeal tumors
2021 C. Peraldo-Neia, P. Ostano, M. Mello-Grand, F. Guana, I. Gregnanin, D. Boschi, S. Oliaro-Bosso, A.C. Pippione, A. Carenzo, L. De Cecco, S. Cavalieri, A. Micali, F. Perrone, G. Averono, P. Bagnasacco, R. Dosdegani, L. Masini, M. Krengli, P. Aluffi-Valletti, G. Valente, G. Chiorino
An old but still unanswered question in recurrent or metastatic salivary duct carcinoma
2021 S. Cavalieri, L.D. Locati, L. Licitra
Baseline mri-radiomics can predict overall survival in non-endemic ebv-related nasopharyngeal carcinoma patients
2020 M. Bologna, V. Corino, G. Calareso, C. Tenconi, S. Alfieri, N.A. Iacovelli, A. Cavallo, S. Cavalieri, L. Locati, P. Bossi, D.A. Romanello, R. Ingargiola, T. Rancati, E. Pignoli, S. Sdao, M. Pecorilla, N. Facchinetti, A. Trama, L. Licitra, L. Mainardi, E. Orlandi
Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review
2021 P. Loap, B. Vischioni, M. Bonora, R. Ingargiola, S. Ronchi, V. Vitolo, A. Barcellini, L. Goanta, L. De Marzi, R. Dendale, R. Pacelli, L. Locati, V. Calugaru, H. Mammar, S. Cavalieri, Y. Kirova, E. Orlandi
Bleeding complications in patients with squamous cell carcinoma of the head and neck
2021 C. Bergamini, R.L. Ferris, J. Xie, G. Mariani, M. Ali, W.C. Holmes, K. Harrington, A. Psyrri, S. Cavalieri, L. Licitra
Bone fracture as a novel immune-related adverse event with immune checkpoint inhibitors: case series and large-scale pharmacovigilance analysis
2021 D.M. Filippini, M. Gatti, V. Di Martino, S. Cavalieri, M. Fusaroli, A. Ardizzoni, E. Raschi, L. Licitra
Clinical implications for pro-GRP in small cell lung cancer. A single center experience
2018 S. Cavalieri, D. Morelli, A. Martinetti, G. Galli, F. Nichetti, F.G.M. DE BRAUD, M. Platania
Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting
2019 R. Depenni, M. Cossu Rocca, D. Ferrari, G. Azzarello, C. Baldessari, M. Alu, F. Nole, C. Codeca, G. Boscolo, M. Piccininni, S. Cavalieri, P. Bossi
Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus-Positive Oropharyngeal Carcinoma
2021 S. Cavalieri, M. Serafini, A. Carenzo, S. Canevari, R. Brakenhoff, C. Leemans, I. Nauta, F. Hoebers, M. van den Hout, K. Scheckenbach, T. Hoffmann, L. De Cecco
Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective Analysis
2019 G. Galli, S. Cavalieri, L. Di Guardo, C. Cimminiello, F. Nichetti, F. Corti, M. Garcia, B. Pappalardi, C. Fallai, F. de Braud, M. Platania, M. Del Vecchio
Combined therapy with dabrafenib and trametinib in BRAF-mutated metastatic melanoma in a real-life setting : the INT Milan experience
2016 S. Cavalieri, L. Di Guardo, C. Cimminiello, A. Bono, E. Tolomio, A. Colombetti, B. Valeri, G. Di Tolla, F. de Braud, M. Del Vecchio
Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy
2020 S. Keek, S. Sanduleanu, F. Wesseling, R. de Roest, M. van den Brekel, M. van der Heijden, C. Vens, C. Giuseppina, L. Licitra, K. Scheckenbach, M. Vergeer, C.R. Leemans, R.H. Brakenhoff, I. Nauta, S. Cavalieri, H.C. Woodruff, T. Poli, R. Leijenaar, F. Hoebers, P. Lambin
Current status and perspectives in immunotherapy for metastatic melanoma
2018 R. Marconcini, F. Spagnolo, L.S. Stucci, S. Ribero, E. Marra, F.D. de Rosa, V. Picasso, L.D. di Guardo, C. Cimminiello, S. Cavalieri, L. Orgiano, E. Tanda, L. Spano, A. Falcone, P. Queirolo, G. Palmieri, I. Stanganelli, M. Mandala, P. Quaglino, G. Botti, C. Caraco, V.C. Sileni, A.M. di Giacomo
Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project
2020 S. Cavalieri, L. De Cecco, R.H. Brakenhoff, M.S. Serafini, S. Canevari, S. Rossi, D. Lanfranco, F.J.P. Hoebers, F.W.R. Wesseling, S. Keek, K. Scheckenbach, D. Mattavelli, T. Hoffmann, L. Lopez Perez, G. Fico, M. Bologna, I. Nauta, C.R. Leemans, A. Trama, T. Klausch, J.H. Berkhof, V. Tountopoulos, R. Shefi, L. Mainardi, F. Mercalli, T. Poli, L. Licitra
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer
2018 S. Cavalieri, F. Perrone, R. Miceli, P.A. Ascierto, L.D. Locati, C. Bergamini, R. Granata, S. Alfieri, C. Resteghini, D. Galbiati, A. Busico, N. Paielli, R. Patuzzo, A. Maurichi, G. Gallino, R. Ruggeri, L. Mariani, M. Palla, L. Licitra, P. Bossi